The Centers for Disease Control and Prevention last week issued a with information on the multistate outbreak of severe pulmonary disease associated with using e-cigarette products. The advisory provides background on e-cigarette products, as well as recommendations for clinicians, public health officials and the public based on currently available information. As of Aug. 27, health departments from 25 states have reported 215 possible cases of pulmonary illnesses from users of e-cigarette products, resulting in one death, and additional reports are under investigation.
 
Health and Human Services Secretary Alex Azar said the department is 鈥渦sing every tool we have to get to the bottom of this deeply concerning outbreak of illnesses in Americans who use e-cigarettes. More broadly, we will continue using every regulatory and enforcement power we have to stop the epidemic of youth e-cigarette use. This situation, and the rising tide of youth tobacco use, is a top public health priority for the Trump Administration and every leader at HHS.鈥

Related News Articles

Headline
A New England Journal of Medicine study published yesterday found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer鈥
Headline
Overall cancer death rates declined steadily among both men and women from 2018 through 2022, according to the National Institutes of Health's latest annual鈥
Headline
A study published April 14 by JAMA Network Open found that rates of pancreatic and colon cancer rose among young adults from 2000-2021. Researchers examined鈥
Headline
The Centers for Medicare & Medicaid Services April 10 released key priorities for new CMS Administrator Mehmet Oz, who was confirmed to the position April鈥
Headline
People under age 50 who consume cannabis are 6.2 times more likely to experience a heart attack than individuals who do not, according to a study published by鈥
Headline
A study published March 26 by the National Institutes of Health and the University of Oxford found that individuals who engaged in light and moderate-to-鈥